Rohto Pharmaceutical to Test Coronavirus Drug That Uses Stem Cells
Newsfrom JapanEconomy Health Science Japan in Video
Rohto Pharmaceutical will start in August a clinical trial of a new drug to treat novel coronavirus patients. The medicine uses mesenchymal stem cells that can regenerate bones and blood vessels.
[© Nippon TV News 24 Japan]